Growth of the global thyroid ablation devices market is
majorly driven by increase in prevalence of thyroid cancer and thyroid nodules;
increase in demand of minimally invasive surgeries; and increase in
availability of new technologically advanced products for the thyroid ablation.
Therefore, these aforementioned factors increase the use of thyroid ablation,
which drives the growth of the thyroid ablation devices market. According to
the American Cancer Society's (ACS) publications, Cancer Facts & Figures 2021
and Cancer Facts & Figures 2020, an estimated 44,280 adults (12,150 men and
32,130 women) in the U.S. were diagnosed with thyroid cancer.
Request for Sample Report@ https://www.alliedmarketresearch.com/request-sample/13940
Thyroid ablation devices are majorly used for the treatment
of thyroid cancer, and thyroid nodules. A thyroid nodule is an unusual growth
(lump) of thyroid cells in the thyroid gland. Thyroid cancer is a solid tumor
cancer that usually shows up as a nodule, or mass, in the thyroid gland, which
is located at the front base of your throat. It occurs when rogue cells
reproduce too rapidly for the immune system to control. There are several types
of thyroid cancer, but two types — papillary thyroid cancer and follicular
thyroid cancer — are by far the most common, accounting for some 95 percent of
cases.
COVID—19 Impact Analysis
The COVID-19 outbreak is anticipated to have a negative
impact on the global thyroid ablation devices market. All the schedules thyroid
nodule ablation surgery and thyroid cancer ablation surgeries were delayed by 3
to 4 weeks as there non-essential surgery. these aforementioned factors
are anticipated to drive the thyroid ablation devices market during the
forecast period.
The ablation technique is used to treat the tumors and
nodules minimally invasively to reduce the size of thyroid nodules and restore
thyroid function. Radiofrequency Ablation (RFA) is a minimally-invasive
technique performed by an endocrine surgeon guided by ultrasound imaging. The
physician delivers targeted radio waves that disrupts the nodule’s cells,
causing them to shrink as the body absorbs the ablated tissue. RFA also enables
patients to resume normal daily activity with minimal recovery time. While
surgery may involve removing part of the thyroid, RFA maintains thyroid
integrity, which supports improved thyroid function.
Key Market Players
·
Boston Scientific Corporation
·
BVM Medical System
·
Integra LifeSciences
·
Johnson & Johnson
·
Medtronic Plc
·
Medwaves Inc.
·
Olympus Corporation
·
STARmed Co. Ltd.
·
Terumo Corporation
·
Theraclion
0 Comments